Epidarex Capital
Investor profile
Deals
8
distinct rounds
Companies
8
backed
Active span
2015–2024
10 yrs
Total round €
€100M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Scottish Investment Bank - Scottish Enterprise2
- 2Invest1
- BioMedPartners1
- Boehringer Ingelheim Venture Fund1
- Caribou Property Limited1
- Dementia Discovery Fund (DDF)1
- EMBL Ventures1
- Evotec1
- Forbion1
- Future Fund1
- GIMV1
- IP Group1
- Mary Canning1
- Novartis Venture Fund1
- Panakès Partners1
- Scottish Enterprise1
- Sofinnova Partners1
- Taiho Ventures1
- Versant Ventures1
- Vesalius Biocapital III1
- Vulpes Investment Management1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enterprise Therapeutics | UK | 1 | €30M |
| Topas Therapeutics | Germany | 1 | €18M |
| Transine Therapeutics | UK | 1 | €16M |
| Leucid Bio | UK | 1 | €14M |
| Mironid | UK | 1 | €6.0M |
| Theolytics | UK | 1 | €5.5M |
| Caldan Therapeutics | UK | 1 | €5.4M |
| Macomics | UK | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Enterprise Therapeutics | Series B | €30M | 2024-01 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| Transine Therapeutics | Seed | €16M | 2022-06 |
| Leucid Bio | Series A | €14M | 2021-10 |
| Mironid | Series A | €6.0M | 2016-05 |
| Theolytics | Series A | €5.5M | 2021-01 |
| Caldan Therapeutics | Series A | €5.4M | 2015-10 |
| Macomics | Other | €5.0M | 2021-07 |